Who are SymBio Pharmaceuticals's investors?

SymBio Pharmaceuticals's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital, TNP Partners Corporation.

SymBio Pharmaceuticals

4 known investors

Find your way into SymBio Pharmaceuticals

SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.

Biotech Healthtech

Investors · 4

DBJ Capitallisted by DBJ CapitalTokyo · $2.7M – $354M

How we know: DBJ Capital's portfolio page · Not right? Tell us

Nippon Venture Capitallisted by Nippon Venture CapitalTokyo · $1.5M – $269M

SMBC Venture Capitallisted by SMBC Venture CapitalTokyo · $2.3M – $269Mvia Hiroya Ota · inferred

How we know: SMBC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us

TNP Partners Corporationlisted by TNP Partners CorporationYokohama

How we know: TNP Partners Corporation's portfolio page · Not right? Tell us

Frequently asked questions

What does SymBio Pharmaceuticals do?: SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.
Who are SymBio Pharmaceuticals's investors?: SymBio Pharmaceuticals's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital, TNP Partners Corporation.